Rakuten Medical

Rakuten Medical is owned by Rakuten.

Rakuten is one of the...

• Forbes Global 2000 (#1016);
• Nikkei 225;
• Topix.

Rakuten is a company listed under the stock ticker 4755 (JP).

Rakuten has a direct presence in 9 countries.

Rakuten has 22 subsidiaries including Cartera Commerce, Kobo and OverDrive.

They are in:

• Retail35%
• Telecommunications13%
• Other52%

Acquisition, funding and merger involving Rakuten.

• Rakuten Medical has just announced a $119 Million fundraising (posted on March 12 2024).

View the org chart displaying its 21 main executives

Most searched biographies at Rakuten Medical

• Hiroshi Mikitani, Chief Executive Officer and Chairman of the Board
• Hiroshi Mori, Director
• Kentaro Hyakuno, Director

Create your alert
to follow the executive moves at Rakuten Medical.

Rakuten has 2,277 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Histogen has filed for bankruptcy protection  (posted on April 19 2024).
• Bruker has announced the acquisition of NanoString Technologies  (posted on April 18 2024).
• Vertex Pharmaceuticals has announced the acquisition of Alpine Immune Sciences  (posted on April 16 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Vik Bajaj - Director at Interline Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Rakuten Medical

• Rakuten Medical’s Poster Presentation at AACR 2024 Demonstrates Reduction in Photoimmunotherapy-induced Edema in Mice with COX-2 Inhibition - Rakuten Medical - To conquer cancer.
• Rakuten Medical’s Upcoming Poster Presentation at AACR 2024: New Findings in Mouse Study to Manage Edema Associated with Photoimmunotherapy based on the Alluminox™ Platform - Rakuten Medical - To conquer cancer.
• Rakuten Medical Closes $119 Million Series E Financing to Further Develop its Alluminox™ Platform - Rakuten Medical - To conquer cancer.
• Over 20 Presentations on Alluminox Treatment (Photoimmunotherapy) at International Conferences in 2023 - Rakuten Medical - To conquer cancer.
• Three Invited Presentations on Alluminox Treatment (Photoimmunotherapy) at FHNO 2023 - Rakuten Medical - To conquer cancer.
• Rakuten Medical Announces First Patient Treatment in India in Global Phase 3 Trial of Alluminox Treatment (Photoimmunotherapy) using ASP-1929 for Recurrent Head and Neck Cancer - Rakuten Medical - To conquer cancer.
• Rakuten Medical to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 10th, 2024 - Rakuten Medical - To conquer cancer.
• Rakuten Medical Presents AI-based Study in Two Posters on Immune Characteristics in Responders and Cellular Level Drug Quantification of Alluminox Treatment (Photoimmunotherapy) at SITC 2023 - Rakuten Medical - To conquer cancer.
• View more press releases Close

Social media about Rakuten Medical

• Rakuten Medical on Wikipedia, Google News & Yahoo Finance
• Rakuten Medical on LinkedIn, Twitter & YouTube

Contact by email its executives including Hiroshi Mikitani

Call Rakuten Medical at +1 858...

View the org chart

Register to receive your alert

Report an error